| REGISTRATION STATEMENT | ||
| UNDER THE SECURITIES ACT OF 1933 | ||
| Pre-Effective Amendment No. | ☐ | |
| Post-Effective Amendment No. | ☐ | |
| And | ||
| REGISTRATION STATEMENT UNDER THE | ||
| INVESTMENT COMPANY ACT OF 1940 | ||
| Amendment No. |
| Check box if the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans. |
| Check box if any securities being registered on this Form will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933 (“Securities Act”), other than securities offered in connection with a dividend reinvestment plan. |
| Check box if this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto. |
| Check box if this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act. |
| Check box if this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act. |
| when declared effective pursuant to section 8(c) |
| This [post-effective] amendment designates a new effective date for a previously filed [post-effective amendment] [registration statement]. |
| This Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: |
| This Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: |
| This Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: |
| Registered Closed-End Fund (closed-end company that is registered under the Investment Company Act of 1940 (“Investment Company Act”)). |
| Business Development Company (closed-end company that intends or has elected to be regulated as a business development company under the Investment Company Act). |
| Interval Fund (Registered Closed-End Fund or a Business Development Company that makes periodic repurchase offers under Rule 23c-3 under the Investment Company Act). |
| A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form). |
| Well-Known Seasoned Issuer (as defined by Rule 405 under the Securities Act). |
| Emerging Growth Company (as defined by Rule 12b-2 under the Securities Exchange Act of 1934 (“Exchange Act”). |
| If an Emerging Growth Company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. |
| New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing). |
|
1
|
|
| 15 | |
| 17 | |
| 18 | |
| 19 | |
| 21 | |
| 22 | |
| 25 | |
| 26 | |
| 27 | |
| 28 | |
|
31
|
|
|
32
|
|
|
33
|
|
|
34
|
|
|
35
|
|
|
36
|
|
|
45
|
|
|
45
|
|
|
53
|
|
|
54
|
|
|
56
|
|
|
58
|
|
|
73
|
|
|
74
|
|
|
75
|
|
|
76
|
|
|
77
|
|
|
79
|
|
|
80
|
|
|
81
|
|
|
82
|
| • |
Growth or EBITDA positive entities
|
| • |
Companies that require capital but do not want to dilute their equity
|
| • |
Companies that are showing strong cash flow performance with low leverage profiles
|
| • |
Transactions that tend to be attractively priced and have better than normal covenants and amortization due to complexity of the industry
|
| • |
Low debt to enterprise value
|
| • |
Industry leaders and disruptive companies experiencing strong growth
|
| • |
Companies that have raised significant equity capital validating market value
|
| • |
Industry focus typically includes software, hardware, e-commerce, direct to consumer and other fast-growing companies
|
| • |
Liquidity covenants that ensure such company has adequate cash runway
|
| • |
Low debt to enterprise value
|
| • |
Profitable or demonstrated path to near term profitability
|
| • |
Companies that are showing strong cash flow performance with low leverage profiles, but the industries carry regulatory, reputational or other risks
|
| • |
Companies with attractive assets, including, but not limited to, accounts receivable, equipment or real estate
|
| • |
Transactions that tend to be attractively priced and have better than normal covenants and amortization due to complexity of the industry or situation
|
| • |
Low debt to asset value and/or enterprise value ratios
|
| • |
Financing is typically event driven
|
| • |
Companies that are pursuing a merger, acquisition, refinancing, dividend recap, or other strategic liquidity need
|
| • |
Companies that are showing strong cash flow performance with low leverage profiles
|
| • |
Companies that have multiple areas of value and liquidity in addition to the underlying business
|
| • |
Low debt to enterprise value ratios
|
| • |
No Incentive Fee on Income is payable to the Adviser in any quarter in which our Pre-Incentive Fee Net Investment Income does not exceed the “hurdle rate” of 1.75%;
|
| • |
100% of our Pre-Incentive Fee Net Investment Income, if any, that exceeds the “hurdle rate,” but is less than or equal to 2.19% in any quarter (8.76% annualized), will be payable to the Adviser. We refer to
this portion of our Incentive Fee on Income as the catch up. It is intended to provide an Incentive Fee on Income of 20% on all of our Pre-Incentive Fee Net Investment Income when our Pre-Incentive Fee Net Investment Income exceeds 2.19% in
any quarter;
|
| • |
For any quarter in which our Pre-Incentive Fee Net Investment Income exceeds 2.19%, the Incentive Fee on Income shall equal 20% of the amount of our Pre-Incentive Fee Net Investment Income, because the
preferred return and catch up will have been achieved; and
|
| • |
For purposes of computing the Incentive Fee on Income, the calculation methodology will look through derivatives or swaps as if we owned the reference assets directly. Therefore, net interest income, if any,
associated with a derivative or swap (which is defined as the difference between (i) the interest income and transaction fees received in respect of the reference assets of the derivative or swap and (ii) all interest and other expenses
paid by us to the derivative or swap counterparty) will be included in the calculation of Pre-Incentive Fee Net Investment Income for purposes of the Incentive Fee on Income.
|
| • |
First-lien debt. First-lien debt typically is senior on a lien basis to other liabilities in the issuer’s capital structure and has the benefit of a first-priority security interest in assets of
the issuer. The security interest ranks above the security interest of any second-lien lenders in those assets. Our first-lien debt may include stand-alone first-lien loans, “unitranche” loans (including “last out” portions of such
loans), and secured corporate bonds with similar features to these categories of first-lien loans.
|
| • |
Stand-alone first lien loans. Stand-alone first-lien loans are traditional first-lien loans. All lenders in the facility have equal rights to the collateral that is subject to the first-priority
security interest.
|
| • |
Unitranche loans. Unitranche loans (including the “last out” portions of such loans) combine features of first-lien, second-lien and mezzanine debt, generally in a first-lien position. In many
cases, we may provide the issuer most, if not all, of the capital structure above their equity. The primary advantages to the issuer are the ability to negotiate the entire debt financing with one lender and the elimination of intercreditor
issues. “Last out” first-lien loans have a secondary priority behind super-senior “first out” first-lien loans in the collateral securing the loans in certain circumstances. The arrangements for a “last out” first-lien loan are typically
set forth in an “agreement among lenders,” which provides lenders with “first out” and “last out” payment streams based on a single lien on the collateral. Since the “first out” lenders generally have priority over the “last out” lenders
for receiving payment under certain specified events of default, or upon the occurrence of other triggering events under intercreditor agreements or agreements among lenders, the “last out” lenders bear a greater risk and, in exchange,
receive a higher effective interest rate, through arrangements among the lenders, than the “first out” lenders or lenders in stand-alone first-lien loans. Agreements among lenders also typically provide greater voting rights to the “last
out” lenders than the intercreditor agreements to which second-lien lenders often are subject. Among the types of first-lien debt in which we may invest, “last out” first-lien loans generally have higher effective interest rates than other
types of first-lien loans, since “last out” first-lien loans rank below standalone first-lien loans.
|
| • |
Second-lien debt. Our second-lien debt may include secured loans, and, to a lesser extent, secured corporate bonds, with a secondary priority behind first-lien debt. Second-lien debt typically is
senior on a lien basis to unsecured liabilities in the issuer’s capital structure and has the benefit of a security interest over assets of the issuer, though ranking junior to first-lien debt secured by those assets. First-lien lenders and
second-lien lenders typically have separate liens on the collateral, and an intercreditor agreement provides the first-lien lenders with priority over the second-lien lenders’ liens on the collateral.
|
| • |
Mezzanine debt. Structurally, mezzanine debt usually ranks subordinate in priority of payment to first-lien and second-lien debt, is often unsecured, and may not have the benefit of financial
covenants common in first-lien and second-lien debt. However, mezzanine debt ranks senior to common and preferred equity in an issuer’s capital structure. Mezzanine debt investments generally offer lenders fixed returns in the form of
interest payments, which could be paid-in-kind, and may provide lenders an opportunity to participate in the capital appreciation, if any, of an issuer through an equity interest. This equity interest typically takes the form of an equity
co-investment or warrants. Due to its higher risk profile and often less restrictive covenants compared to senior secured loans, mezzanine debt generally bears a higher stated interest rate than first-lien and second-lien debt.
|
| • |
Broadly syndicated loans. Broadly syndicated loans (whose features are similar to those described under “First-lien debt” and “Second-lien debt” above) are typically originated and structured by
banks on behalf of large corporate borrowers with employee counts, revenues, EBITDAs, and enterprise values larger than the middle-market characteristics described above. The proceeds of broadly syndicated loans are often used for leveraged
buyout transactions, mergers and acquisitions, recapitalizations, refinancings, and financing capital expenditures. Broadly syndicated loans are typically distributed by the arranging bank to a diverse group of investors primarily
consisting of: collateralized loan obligations; senior secured loan and high yield bond mutual funds; closed-end funds, hedge funds, banks, and insurance companies; and finance companies. A borrower must comply with various covenants
contained in a loan agreement or note purchase agreement between the borrower and the holders of the broadly syndicated loan. The broadly syndicated loans in which we invest may include loans that are considered “covenant-lite” loans,
because of their lack of a full set of financial maintenance covenants.
|
| • |
requiring a total return on our investments (including both interest and potential equity appreciation) that compensates us for credit risk;
|
| • |
negotiating covenants in connection with our investments consistent with preservation of our capital. Such restrictions may include affirmative covenants (including reporting requirements), negative covenants (including financial
maintenance covenants), lien protection, limitations on debt incurrence, restrictions on asset sales, downside and liquidation cases, restrictions on dividends and other payments, cash flow sweeps, collateral protection, required debt
amortization, change of control provisions and board rights, including either observation rights or rights to a seat on the board under some circumstances; and
|
| • |
including debt amortization requirements, where appropriate, to require the timely repayment of principal of the loan, as well as appropriate maturity dates.
|
| Shareholder transaction expenses: | |||||
| Sales load (as a percentage of offering price) | | % | (1) | ||
| Offering expenses (as a percentage of offering price) | | % | (2) | ||
| Total shareholder transaction expenses ( | | % | |||
| Annual expenses (as a percentage of net assets attributable to common stock): | |||||
| Base management fee payable under the Investment Advisory Agreement | | % | (3) | ||
| Incentive fee payable under the Investment Advisory Agreement | | % | (4) | ||
| Interest payments on borrowed funds | | % | (5) | ||
| Other expenses | | % | (6) | ||
| Total annual expenses | | % | |||
| (1) | |
| (2) | |
| (3) | |
| (4) | |
| (5) | |
| (6) | |
| | 1 year | 3 years | 5 years | 10 years | ||||||||||||
| You would pay the following expenses on a $1,000 common stock investment, assuming a 5% annual return (assumes no return from net realized capital gains) (none of which is subject to the capital gains incentive fee) | $ | | $ | | $ | | $ | | ||||||||
| You would pay the following expenses on a $1,000 common stock investment, assuming a 5% annual return resulting entirely from net realized capital gains (all of which is subject to the capital gains incentive fee) | $ | | $ | | $ | | $ | | ||||||||
| • |
uncertainties related to the new U.S. Presidential administration, including the potential impact of tariff enactment and tax reductions, and the risk of recession or a shutdown of government services, which could impact our business
prospects and the prospects of our portfolio companies;
|
| • |
our future operating results and distribution projections;
|
| • |
the ability of the Adviser to attract and retain highly talented professionals;
|
| • |
our business prospects and the prospects of our portfolio companies;
|
| • |
the impact of interest and inflation rates on our business prospects and the prospects of our portfolio companies;
|
| • |
the impact of the investments that we expect to make;
|
| • |
the ability of our portfolio companies to achieve their objectives;
|
| • |
our expected financings and investments and the timing of our investments in our initial portfolio;
|
| • |
changes in regulation impacting the cannabis industry;
|
| • |
the adequacy of our cash resources and working capital;
|
| • |
the timing of cash flows, if any, from the operations of our portfolio companies;
|
| • |
the ability to realize benefits anticipated by the previously announced acquisition from Chicago Atlantic Loan Portfolio, LLC (“CALP”) of a portfolio of loans (the “Loan Portfolio”) in exchange for newly issued shares of the Company’s common
stock (the “Loan Portfolio Acquisition”);
|
| • |
changes or potential disruptions in our operations, the economy, financial markets or political environment;
|
| • |
risks associated with possible disruption in our operations or the economy generally due to terrorism, natural disasters, the conflicts between Russia and Ukraine and in the Middle East, and the potential for
volatility in energy prices and other commodities and their impact on the industries in which we invest;
|
| • |
the impact of information technology system failures, data security breaches, data privacy compliance, network disruptions, and cybersecurity attacks; and
|
| • |
future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities) and conditions in our operating areas, particularly with respect to BDCs or RICs.
|
| Net Asset | Price Range | High Sales Price Premium (Discount) to Net Asset | Low Sales Price Premium (Discount) to Net Asset | Cash Dividend Per | ||||||||||||||||||||
| Class and Period | Value(1) | High | Low | Value(2) | Value(2) | Share(3) | ||||||||||||||||||
| Year Ended December 31, 2026 | ||||||||||||||||||||||||
| Second Quarter (Through May 7, 2026) | * | $ | $ | * | * | |||||||||||||||||||
| First Quarter | * | $ | | $ | | * | * | $ | | (6) | ||||||||||||||
| Year Ended December 31, 2025 | ||||||||||||||||||||||||
| Fourth Quarter | $ | | $ | | $ | | - | % | - | % | $ | | ||||||||||||
| Third Quarter | $ | | $ | | $ | | - | % | - | % | $ | | ||||||||||||
| Second Quarter | $ | | $ | | $ | | - | % | - | % | $ | | ||||||||||||
| First Quarter | $ | | $ | | $ | | - | % | - | % | $ | | ||||||||||||
| Year Ended December 31, 2024 | ||||||||||||||||||||||||
| Fourth Quarter | $ | | $ | | $ | | | % | - | % | $ | | ||||||||||||
| Third Quarter | $ | | $ | | $ | | - | % | - | % | $ | | ||||||||||||
| Second Quarter | $ | | $ | | $ | | - | % | - | % | $ | | ||||||||||||
| First Quarter | $ | | $ | | $ | | - | % | - | % | $ | | ||||||||||||
| Year Ended December 31, 2023 | ||||||||||||||||||||||||
| Fourth Quarter | $ | | $ | | $ | | - | % | - | % | $ | | (7) | |||||||||||
| Third Quarter | $ | | $ | | $ | | - | % | - | % | $ | | (7) | |||||||||||
| Second Quarter | $ | | $ | | $ | | - | % | - | % | ||||||||||||||
| First Quarter | $ | | $ | | $ | | - | % | - | % | ||||||||||||||
| Year Ended December 31, 2022(4) | ||||||||||||||||||||||||
| Fourth Quarter | $ | | $ | | $ | | - | % | - | % | | |||||||||||||
| Third Quarter | $ | | $ | | $ | | - | % | - | % | | |||||||||||||
| Second Quarter | $ | | $ | | $ | | - | % | - | % | | |||||||||||||
| First Quarter(5) | $ | | $ | | $ | | | % | - | % | | |||||||||||||
| (1) | |
| (2) | |
| (3) | |
| (4) | |
| (5) | |
| (6) | |
| (7) |
Consists of a quarterly dividend and a special dividend.
|
| • |
98% of our net ordinary income, excluding certain ordinary gains and losses, recognized during a calendar year;
|
| • |
98.2% of our capital gain net income, adjusted for certain ordinary gains and losses, recognized for the twelve-month period ending on October 31 of such calendar year; and
|
| • |
100% of any ordinary income and capital gain net income that we recognized in preceding years, but were not distributed in such years, and on which we paid no U.S. federal income tax.
|
|
Declaration Date
|
Type
|
Record Date
|
Payment Date
|
Per Share
Amount
|
Dividends
Declared
|
|||||||||
|
August 10, 2023
|
Quarterly
|
September 15, 2023
|
September 29, 2023
|
$
|
0.23
|
$
|
1,429,375
|
|||||||
|
August 10, 2023
|
Special
|
September 15, 2023
|
September 29, 2023
|
$
|
0.40
|
$
|
2,485,869
|
|||||||
|
November 9, 2023
|
Quarterly
|
December 20, 2023
|
December 29, 2023
|
$
|
0.25
|
$
|
1,553,676
|
|||||||
|
November 9, 2023
|
Special
|
December 20, 2023
|
December 29, 2023
|
$
|
0.45
|
$
|
2,796,617
|
|||||||
|
March 8, 2024
|
Quarterly
|
March 20, 2024
|
March 28, 2024
|
$
|
0.25
|
$
|
1,553,736
|
|||||||
|
May 9, 2024
|
Quarterly
|
June 20, 2024
|
June 28, 2024
|
$
|
0.25
|
$
|
1,553,738
|
|||||||
|
August 8, 2024
|
Quarterly
|
September 19, 2024
|
September 27, 2024
|
$
|
0.25
|
$
|
1,553,741
|
|||||||
|
December 9, 2024
|
Quarterly
|
December 19, 2024
|
December 27, 2024
|
$
|
0.34
|
$
|
7,758,925
|
|||||||
|
March 14, 2025
|
Quarterly
|
March 28, 2025
|
April 11, 2025
|
$
|
0.34
|
$
|
7,758,931
|
|||||||
|
May 12, 2025
|
Quarterly
|
June 27, 2025
|
July 11, 2025
|
$
|
0.34
|
$
|
7,758,939
|
|||||||
|
August 14, 2025
|
Quarterly
|
September 29, 2025
|
October 10, 2025
|
$
|
0.34
|
$
|
7,759,001
|
|||||||
|
November 11, 2025
|
Quarterly
|
December 31, 2025
|
January 15, 2026
|
$
|
0.34
|
$
|
7,759,001
|
|||||||
|
Declaration Date
|
Type
|
Record Date
|
Payment Date
|
Shares
|
||||
|
March 14, 2025
|
Quarterly
|
March 28, 2025
|
April 11, 2025
|
22
|
||||
|
May 12, 2025
|
Quarterly
|
June 27, 2025
|
July 11, 2025
|
182
|
|
Portfolio Company
|
|
Address
|
Nature of
Business
|
Investment
Type
|
Fair
Value
|
Interest
Terms1
|
Maturity
|
Relationship
|
||||||
|
Action Target, Inc.
|
|
3411 S. Mountain Vista Parkway
Provo, UT 84606 |
|
Manufacturing
|
|
Delayed Draw Term Loan
|
$
|
2,440,172
|
|
12.00% (P + 2.00%; 1.50% PIK; 8.50% Floor)
|
|
7/19/2027
|
|
Non-Control,
Non-Affiliate
|
|
Aeriz Holdings Corp
|
351 W. Hubbard Street
Chicago, IL 60654 |
Cannabis
|
Delayed Draw Term Loan
|
9,589,710
|
12.50% (P + 5.75%)
|
6/30/2028
|
Non-Control,
Non-Affiliate
|
|||||||
|
AI Software, LLC (d/b/a Capacity)
|
|
6665 Delmar Blvd., Suite 300
St. Louis, MO 63130 |
|
Information
|
|
Delayed Draw Term Loan
|
|
5,094,858
|
|
16.00% (P + 6.50%; 2.00% PIK; 7.50% Floor)
|
|
6/13/2029
|
|
Non-Control,
Non-Affiliate
|
|
AI Software, LLC (d/b/a Capacity)
|
6665 Delmar Blvd., Suite 300
St. Louis, MO 63130 |
Information
|
Warrants
|
539,000
|
n.a
|
n.a
|
Non-Control,
Non-Affiliate
|
|||||||
|
Archos Capital Group, LLC
|
|
1504 N. Highland Avenue
Arlington Heights, IL 60004 |
|
Cannabis
|
|
Delayed Draw Term Loan
|
|
113,065
|
|
14.25% (P + 5.75%; 8.50% Floor)
|
|
1/5/2026
|
|
Non-Control,
Non-Affiliate
|
|
Ascend Wellness Holdings, Inc.
|
174 NJ-17
Rochelle Park, NJ 07662 |
Cannabis
|
Senior Secured Note
|
3,482,500
|
12.75% (F @ 12.75%)
|
7/16/2029
|
Non-Control,
Non-Affiliate
|
|||||||
|
Aura Home, Inc
|
|
30 Cooper Square, Floor 8
New York, NY 10003-7120 |
|
Retail Trade
|
|
Term Loan
|
|
3,308,375
|
|
10.77% (S + 6.50%; 3.75% Floor)
|
|
9/22/2026
|
|
Non-Control,
Non-Affiliate
|
|
Aura Home, Inc
|
30 Cooper Square, Floor 8
New York, NY 10003-7120 |
Retail Trade
|
Term Loan
|
516,336
|
10.77% (S + 6.50%; 3.75% Floor)
|
9/22/2026
|
Non-Control,
Non-Affiliate
|
|||||||
|
BeLeaf Medical, LLC
|
|
1551 Wall Street, Suite 280
Saint Charles, Missouri 63303 |
|
Cannabis
|
|
Term Loan
|
|
14,074,362
|
|
13.25% (P + 5.75%; 7.50% Floor)
|
|
8/20/2028
|
|
Non-Control,
Non-Affiliate
|
|
CO Acquisition Vehicle, LLC
|
5845 Centre Avenue
Pittsburgh, PA 15206 |
Cannabis
|
Term Loan
|
15,521,257
|
20.00% (F @ 0.00%; 20.00% PIK)
|
12/31/2029
|
Non-Control,
Non-Affiliate
|
|||||||
|
Cresco Labs, LLC
|
|
600 West Fulton Street, Suite 800
Chicago, IL 60661 |
|
Cannabis
|
|
Term Loan
|
|
7,162,500
|
|
12.50% (F @ 12.50%)
|
|
8/13/2030
|
|
Non-Control,
Non-Affiliate
|
|
Curaleaf Holdings, Inc.
|
Burrard Street, Suite 1700-666
Vancouver, British Columbia, Canada |
Cannabis
|
Senior Secured Note
|
8,330,000
|
8.00% (F @ 8.00%)
|
12/15/2026
|
Non-Control,
Non-Affiliate |
|||||||
|
Dreamfields Brands, Inc. (d/b/a Jeeter)
|
|
65441 Two Bunch Palms Trail
Desert Hot Springs, CA 92240 |
|
Cannabis
|
|
Delayed Draw Term Loan
|
|
31,745,000
|
|
16.25% (P + 8.75%; 7.50% Floor)
|
|
9/30/2028
|
|
Non-Control,
Non-Affiliate
|
|
Elevation Cannabis, LLC
|
6120 E Connecticut Avenue
Kansas City, MO 64120 |
Cannabis
|
Delayed Draw Term Loan
|
10,767,866
|
16.25% (P + 7.75%; 8.50% Floor)
|
12/31/2026
|
Non-Control,
Non-Affiliate
|
|||||||
|
Energize Holdings, Inc. (d/b/a Exos)
|
|
2629 E. Rose Garden Lane
Phoenix, AZ 85050 |
|
Educational Services
|
|
Term Loan
|
|
4,966,078
|
|
11.99% (S + 8.00%; 3.99% Floor)
|
|
10/24/2029
|
|
Non-Control,
Non-Affiliate
|
|
Energize Holdings, Inc. (d/b/a Exos)
|
2629 E. Rose Garden Lane
Phoenix, AZ 85050 |
Educational Services
|
Warrants
|
35,603
|
n.a
|
n.a
|
Non-Control,
Non-Affiliate
|
|||||||
|
Engage3 Holdings, Inc.
|
|
9375 E. Shea Boulevard, Suite 100
Scottsdale, AZ 85260 |
|
Information
|
|
Term Loan
|
|
5,784,080
|
|
14.00% (P + 2.50%; 4.00% PIK; 7.50% Floor)
|
|
7/22/2030
|
|
Non-Control,
Non-Affiliate
|
|
Engage3 Holdings, Inc.
|
9375 E. Shea Boulevard, Suite 100
Scottsdale, AZ 85260 |
Information
|
Warrants
|
268,000
|
n.a
|
n.a
|
Non-Control,
Non-Affiliate
|
|||||||
|
Flowery - Bill's Nursery, Inc.
|
|
30003 SW 197 Avenue
Homestead, FL 33030 |
|
Cannabis
|
|
Delayed Draw Term Loan
|
|
13,908,331
|
|
16.00% (F @ 11.00%; 5.00% PIK)
|
|
12/31/2027
|
|
Non-Control,
Non-Affiliate
|
|
Portfolio Company
|
Address |
Nature of
Business
|
Investment
Type
|
Fair
Value
|
Interest
Terms1
|
Maturity | Relationship | |||||||
|
FLUENT Corp.
|
5540 W. Executive Drive, Suite 100
Tampa, FL 33609 |
Cannabis
|
Term Loan
|
8,311,228
|
13.00% (F @ 12.00%; 1.00% PIK)
|
11/24/2028
|
Non-Control,
Non-Affiliate
|
|||||||
|
HA-MD, LLC
|
|
1007 Church Road, Bear
Delaware 19702 |
|
Cannabis
|
|
Term Loan
|
|
2,870,000
|
|
15.00% (F @ 15.00%)
|
|
6/6/2026
|
|
Non-Control,
Non-Affiliate
|
|
Hugo Technologies, Inc.
|
401 N. Michigan Ave., Suite 1200
Chicago, IL 60611 |
Administrative and Support and Waste Management and Remediation Services
|
Term Loan
|
3,000,000
|
11.79% (S + 8.00%; 3.25% Floor)
|
12/10/2030
|
Non-Control,
Non-Affiliate
|
|||||||
|
Illicit - S1 Enterprises, Inc.
|
|
3823 N. Cobbler Road
Independence, MO 64058 |
|
Cannabis
|
|
Term Loan
|
|
14,610,356
|
|
13.96% (S + 10.24%; 3.72% Floor)
|
|
12/31/2028
|
|
Non-Control,
Non-Affiliate
|
|
Kaleafa, Inc.
|
16489 Oaktree Terrace
Oregon City, Oregon 97045 |
Cannabis
|
Term Loan
|
2,768,319
|
17.00% (P + 8.50%; 8.50% Floor)
|
12/3/2027
|
Non-Control,
Non-Affiliate
|
|||||||
|
Kapple Holdings LLC (Cannabis & Glass)
|
|
605 East Francis Avenue
Spokane, WA 99208
|
|
Cannabis
|
|
Delayed Draw Term Loan
|
|
3,685,000
|
|
14.53% (S + 10.25%; 4.00% Floor)
|
|
7/28/2028
|
|
Non-Control,
Non-Affiliate
|
|
Nova Farms, LLC
|
1000 Washington Street
Attleboro, MA 02703 |
Cannabis
|
Term Loan
|
13,770,063
|
15.00% (P + 6.50%; 8.50% Floor)
|
3/28/2027
|
Non-Control,
Non-Affiliate
|
|||||||
|
Oasis - AZ GOAT AZ LLC
|
|
30 N Gould St., Suite R
Sheridan, WY 82801 |
|
Cannabis
|
|
Term Loan
|
|
4,295,859
|
|
15.50% (P + 7.50%; 8.00% Floor)
|
|
3/31/2027
|
|
Non-Control,
Non-Affiliate
|
|
Ocular Science, Inc.
|
118 Center Street
El Segundo, CA 90245 |
Manufacturing
|
Term Loan
|
4,851,017
|
13.00% (P + 5.25%; 1.00% PIK; 6.75% Floor)
|
6/17/2029
|
Non-Control,
Non-Affiliate
|
|||||||
|
Ocular Science, Inc.
|
|
118 Center Street
El Segundo, CA 90245 |
|
Manufacturing
|
|
Warrants
|
|
150,752
|
|
n.a
|
|
n.a
|
|
Non-Control,
Non-Affiliate
|
|
Portofino Labs, Inc. (dba Because Market)
|
350 Cambridge Ave, Suite 100
Palo Alto, CA 94306 |
Retail Trade
|
Term Loan
|
5,070,190
|
12.03% (S + 6.25%; 1.50% PIK; 4.25% Floor)
|
4/30/2029
|
Non-Control,
Non-Affiliate
|
|||||||
|
Portofino Labs, Inc. (dba Because Market)
|
|
350 Cambridge Ave, Suite 100
Palo Alto, CA 94306 |
|
Retail Trade
|
|
Warrants
|
|
19,250
|
|
n.a
|
|
n.a
|
|
Non-Control,
Non-Affiliate
|
|
Protect Animals With Satellites LLC (Halo Collar)
|
50 Tice Boulevard, Suite 340
Woodcliff Lake, NJ 07677 |
Information
|
Term Loan
|
3,470,145
|
13.25% (P + 1.75%; 3.00% PIK; 8.50% Floor)
|
11/1/2026
|
Non-Control,
Non-Affiliate
|
|||||||
|
Protect Animals With Satellites LLC (Halo Collar)
|
|
50 Tice Boulevard, Suite 340
Woodcliff Lake, NJ 07677 |
|
Information
|
|
Incremental Term Loan
|
|
1,802,485
|
|
13.25% (P + 1.75%; 3.00% PIK; 8.50% Floor)
|
|
11/1/2026
|
|
Non-Control,
Non-Affiliate
|
|
Remedy - Maryland Wellness, LLC
|
4128 Hayward Ave. Baltimore, MD 21215
|
Cannabis
|
Delayed Draw Term Loan
|
1,447,186
|
20.25% (P + 9.00%; 3.50% PIK; 7.75% Floor)
|
8/1/2028
|
Non-Control,
Non-Affiliate
|
|||||||
|
RTCP, LLC
|
|
4215 E McDowell Rd #108
Mesa, AZ 85215 |
|
Finance and Insurance
|
|
Senior Secured Note
|
|
22,000,000
|
|
15.00% (F @ 15.00%)
|
|
10/2/2028
|
|
Non-Control,
Non-Affiliate
|
|
Shangri-La Columbia, LLC
|
1401 Creekwood Parkway
Columbia, MO 65202 |
Cannabis
|
Delayed Draw Term Loan
|
11,343,000
|
13.25% (P + 5.75%; 7.50% Floor)
|
6/30/2028
|
Non-Control,
Non-Affiliate
|
|||||||
|
Silver Therapeutics, Inc.
|
|
89 Court Street
Saratoga Springs, NY 12866 |
|
Cannabis
|
|
Delayed Draw Term Loan
|
|
6,009,300
|
|
15.00% (P + 7.25%; 7.75% Floor)
|
|
3/24/2028
|
|
Non-Control,
Non-Affiliate
|
|
Subsero Holdings - Illinois, Inc
|
1000 S Old Woodward Ave, Suite 105
Birmingham, MI 48009 |
Cannabis
|
Delayed Draw Term Loan
|
2,791,834
|
16.00% (P + 7.00%; 2.00% PIK; 7.00% Floor)
|
7/29/2026
|
Non-Control,
Non-Affiliate
|
|||||||
|
TerrAscend Corporation
|
|
77 City Centre Drive Suite 501 - East Tower
Mississauga, Ontario, Canada |
|
Cannabis
|
|
Term Loan
|
|
2,936,905
|
|
12.75% (F @ 12.75%)
|
|
8/1/2028
|
|
Non-Control,
Non-Affiliate
|
|
TheraTrue, Inc.
|
4062 Peachtree Road SE, Suite A300
Atlanta, Georgia 30319 |
Cannabis
|
Delayed Draw Term Loan
|
3,015,571
|
14.50% (F @ 14.50%)
|
3/13/2027
|
Non-Control,
Non-Affiliate
|
|||||||
|
Tulip.io Inc.
|
|
210-137 Glasgow Street, Office #192
Kitchener, N2G 4X8, Ontario, Canada |
|
Information
|
|
Term Loan
|
|
3,052,998
|
|
15.00% (P + 4.00%; 3.00% PIK; 8.00% Floor)
|
|
11/4/2028
|
|
Non-Control,
Non-Affiliate
|
|
Tulip.io Inc.
|
210-137 Glasgow Street, Office #192
Kitchener, N2G 4X8, Ontario, Canada |
Information
|
Warrants
|
-
|
n.a
|
n.a
|
Non-Control,
Non-Affiliate
|
|
Portfolio
Company
|
Address |
Nature of
Business
|
Investment
Type
|
Fair
Value
|
Interest
Terms1
|
Maturity | Relationship | |||||||
|
Verano Holdings Corp.
|
|
224 W Hill Street, Suite 400
Chicago, IL 60610 |
|
Cannabis
|
|
Term Loan
|
|
42,248,731
|
|
13.25% (P + 6.50%; 6.25% Floor)
|
|
10/30/2026
|
|
Non-Control,
Non-Affiliate
|
|
Verano Holdings Corp.
|
224 W Hill Street, Suite 400
Chicago, IL 60610 |
Cannabis
|
Revolver
|
10,000,000
|
12.49% (S + 8.33%; 4.00% Floor)
|
9/29/2028
|
Non-Control,
Non-Affiliate
|
|||||||
|
Wellgreens 2.0, LLC
|
|
6859 Federal Blvd., Suite B
Lemon Grove, CA 91945
|
|
Cannabis
|
|
Term Loan
|
|
4,332,519
|
|
14.00% (P + 6.50%; 7.50% Floor)
|
|
7/31/2029
|
|
Non-Control,
Non-Affiliate
|
|
West Creek Financial Holdings, Inc. dba Koalafi
|
424 Hull Street, Suite 600,
Richmond, VA 23224 |
Finance and Insurance
|
Series A Senior Note
|
3,660,999
|
18.80% (F @ 13.80%; 5.00% PIK)
|
11/29/2027
|
Non-Control,
Non-Affiliate
|
|||||||
|
Workbox Holdings, Inc.
|
|
420 North Wabash Avenue, Suite 500
Chicago, IL 60611 |
|
Real Estate and Rental and Leasing
|
|
Term Loan
|
|
1,987,879
|
|
12.00% (F @ 6.00%; 6.00% PIK)
|
|
5/31/2029
|
|
Non-Control,
Non-Affiliate
|
|
Workbox Holdings, Inc.
|
420 North Wabash Avenue, Suite 500
Chicago, IL 60611 |
Real Estate and Rental and Leasing
|
A-1 Preferred
|
500,000
|
n.a
|
n.a
|
Non-Control,
Non-Affiliate
|
|||||||
|
Workbox Holdings, Inc.
|
|
420 North Wabash Avenue, Suite 500
Chicago, IL 60611 |
|
Real Estate and Rental and Leasing
|
|
A-3 Warrants
|
|
44,000
|
|
n.a
|
|
n.a
|
|
Non-Control,
Non-Affiliate
|
|
Workbox Holdings, Inc.
|
420 North Wabash Avenue, Suite 500
Chicago, IL 60611 |
Real Estate and Rental and Leasing
|
A-4 Warrants
|
115,000
|
n.a
|
n.a
|
Non-Control,
Non-Affiliate
|
|||||||
|
Youth Opportunity Investments, LLC
|
|
12775 Horseferry Rd #230
Carmel, IN 46032 |
|
Public Administration
|
|
Term Loan
|
|
11,504,108
|
|
12.02% (S + 7.75%; 4.00% Floor)
|
|
9/18/2026
|
|
Non-Control,
Non-Affiliate
|
| • |
a citizen or individual resident of the United States;
|
| • |
a corporation, or other entity treated as a corporation, created or organized in or under the laws of the United States or any state thereof or the District of Columbia;
|
| • |
an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or
|
| • |
a trust if (1) a U.S. court is able to exercise primary supervision over the administration of such trust and one or more U.S. persons have the authority to control all substantial decisions of the trust or (2) it has a valid election
in place to be treated as a domestic trust for U.S. federal income tax purposes.
|
| • |
continue to qualify as a BDC or be registered as a management investment company under the 1940 Act at all times during each taxable year;
|
| • |
derive in each taxable year at least 90% of our gross income from dividends, interest, payments with respect to certain securities loans, gains from the sale or other disposition of stock or other securities or foreign currencies,
other income derived with respect to our business of investing in such stock, securities or foreign currencies and net income derived from an interest in a “qualified publicly traded partnership” (as defined in Subchapter M of the Code),
or the “90% Income Test”;
|
| • |
satisfy the Annual Distribution Requirement; and
|
| • |
diversify our holdings so that at the end of each quarter of the taxable year:
|
| • |
at least 50% of the value of our assets consists of cash, cash equivalents, U.S. Government securities, securities of other RICs, and other securities if such other securities of any one issuer do not represent more than 5% of the
value of our assets or more than 10% of the outstanding voting securities of the issuer (which for these purposes includes the equity securities of a “qualified publicly traded partnership”); and
|
| • |
no more than 25% of the value of our assets is invested in (i) the securities, other than U.S. government securities or securities of other RICs, of one issuer (ii) the securities, other than securities of other RICs, of two or more
issuers that are controlled, as determined under applicable tax rules, by us and that are engaged in the same or similar or related trades or businesses or (iii) the securities of one or more “qualified publicly traded partnerships,” or
the Diversification Tests.
|
| Title of Class | Amount Authorized | Amount Held by Us or for Our Account | Amount Outstanding Exclusive of Amount Held by Us or for Our Account | |||||||||
| | | | | |||||||||
| (a) |
amendments to the provisions of the charter relating to our purpose, the classification of the Board, the power of the Board to fix the number of directors and to fill vacancies on the Board, the vote required to elect or remove a
director, amendments to the charter, extraordinary transactions, and the Board’s exclusive power to amend the bylaws;
|
| (b) |
charter amendments that would convert us from a closed-end company to an open-end company or make our common stock a redeemable security (within the meaning of the 1940 Act);
|
| (c) |
our liquidation or dissolution or any amendment to the charter to effect any such liquidation or dissolution;
|
| (d) |
any merger, consolidation, conversion, share exchange, or sale or exchange of all or substantially all of our assets;
|
| (e) |
transaction between us and any person or group of persons acting together that is entitled to exercise or direct the exercise, or acquire the right to exercise or direct the exercise, directly or indirectly (other than solely by virtue
of a revocable proxy), of one-tenth or more of the voting power in the election of our directors generally, or any person controlling, controlled by, or under common control with, employed by or acting as an agent of, any such person or
member of such group; or
|
| (f) |
issuance or transfer by us (in one transaction or a series of transactions in any 12-month period) of any securities of the Company to any other person in exchange for cash, securities or other property (or a combination thereof)
having an aggregate fair market value (as determined by the Board) of $1,000,000 or more excluding (i) issuances or transfers of debt securities of the Company, (ii) sales of any securities of the Company in connection with a public
offering, (iii) issuances of any securities of the Company pursuant to a dividend reinvestment plan and/or cash purchase plan adopted by us, (iv) issuances of any securities of the Company upon the exercise of any stock subscription
rights distributed by us and (v) portfolio transactions effected by us in the ordinary course of business.
|
| • |
one-tenth or more but less than one-third;
|
| • |
one-third or more but less than a majority; or
|
| • |
a majority or more of all voting power.
|
| • |
any person who beneficially owns 10% or more of the voting power of the corporation’s outstanding voting stock; or
|
| • |
an affiliate or associate of the corporation who, at any time within the two-year period prior to the date in question, was the beneficial owner of 10% or more of the voting power of the then-outstanding voting stock of the
corporation.
|
| • |
80% of the votes entitled to be cast by holders of outstanding shares of voting stock of the corporation; and
|
| • |
two-thirds of the votes entitled to be cast by holders of voting stock of the corporation other than voting stock held by the interested shareholder with whom or with whose affiliate the business combination is to be effected or held
by an affiliate or associate of the interested shareholder.
|
| • |
immediately after issuance and before any distribution is made with respect to common stock, we must meet a coverage ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, of
at least 150%; and
|
| • |
the holders of shares of preferred stock must be entitled as a class to elect two directors at all times and to elect a majority of the directors if and for so long as dividends on the preferred stock are unpaid in an amount equal to
two full years of dividends on the preferred stock.
|
| • |
the designation and number of shares of such class or series;
|
| • |
the rate and time at which, and the preferences and conditions under which, any dividends will be paid on shares of such class or series, as well as whether such dividends are participating or non-participating;
|
| • |
any provisions relating to convertibility or exchangeability of the shares of such class or series, including adjustments to the conversion price of such class or series;
|
| • |
the rights and preferences, if any, of holders of shares of such class or series upon our liquidation, dissolution or winding up of our affairs;
|
| • |
the voting powers, if any, of the holders of shares of such class or series;
|
| • |
any provisions relating to the redemption of the shares of such class or series;
|
| • |
any limitations on our ability to pay dividends or make distributions on, or acquire or redeem, other securities while shares of such class or series are outstanding;
|
| • |
any conditions or restrictions on our ability to issue additional shares of such class or series or other securities;
|
| • |
if applicable, a discussion of certain U.S. federal income tax considerations; and
|
| • |
any other relative powers, preferences and participating, optional or special rights of shares of such class or series, and the qualifications, limitations or restrictions thereof.
|
| • |
the period of time the offering would remain open (which shall be open a minimum number of days such that all record holders would be eligible to participate in the offering and shall not be open longer than 120 days);
|
| • |
the title of such subscription rights;
|
| • |
the exercise price for such subscription rights (or method of calculation thereof);
|
| • |
the ratio of the offering (which, in the case of transferable rights, will require a minimum of three shares to be held of record before a person is entitled to purchase an additional share);
|
| • |
the number of such subscription rights issued to each shareholder;
|
| • |
the extent to which such subscription rights are transferable and the market on which they may be traded if they are transferable;
|
| • |
if applicable, a discussion of certain U.S. federal income tax considerations applicable to the issuance or exercise of such subscription rights;
|
| • |
the date on which the right to exercise such subscription rights shall commence, and the date on which such right shall expire (subject to any extension);
|
| • |
the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege;
|
| • |
any termination right we may have in connection with such subscription rights offering; and
|
| • |
any other terms of such subscription rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such subscription rights.
|
| • |
the title of such warrants;
|
| • |
the aggregate number of such warrants;
|
| • |
the price or prices at which such warrants will be issued;
|
| • |
the currency or currencies, including composite currencies, in which the price of such warrants may be payable;
|
| • |
if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;
|
| • |
in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at which and the currency or currencies, including composite currencies, in which this
principal amount of debt securities may be purchased upon such exercise;
|
| • |
in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or preferred stock, as the case may be, purchasable upon exercise of one warrant and the price at which and the currency or
currencies, including composite currencies, in which these shares may be purchased upon such exercise;
|
| • |
the date on which the right to exercise such warrants shall commence and the date on which such right will expire;
|
| • |
whether such warrants will be issued in registered form or bearer form;
|
| • |
if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time;
|
| • |
if applicable, the date on and after which such warrants and the related securities will be separately transferable;
|
| • |
information with respect to book-entry procedures, if any;
|
| • |
the terms of the securities issuable upon exercise of the warrants;
|
| • |
if applicable, a discussion of certain U.S. federal income tax considerations; and
|
| • |
any other terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants.
|
| • |
the designation or title of the series of debt securities;
|
| • |
the total principal amount of the series of debt securities;
|
| • |
the percentage of the principal amount at which the series of debt securities will be offered;
|
| • |
the date or dates on which principal will be payable;
|
| • |
the rate or rates (which may be either fixed or variable) and/or the method of determining such rate or rates of interest, if any;
|
| • |
the date or dates from which any interest will accrue, or the method of determining such date or dates, and the date or dates on which any interest will be payable;
|
| • |
whether any interest may be paid by issuing additional securities of the same series in lieu of cash (and the terms upon which any such interest may be paid by issuing additional securities);
|
| • |
the terms for redemption, extension or early repayment, if any;
|
| • |
the currencies in which the series of debt securities are issued and payable;
|
| • |
whether the amount of payments of principal, premium or interest, if any, on a series of debt securities will be determined with reference to an index, formula or other method (which could be based on one or more currencies,
commodities, equity indices or other indices) and how these amounts will be determined;
|
| • |
the place or places, if any, other than or in addition to the Borough of Manhattan in the City of New York, of payment, transfer, conversion and/or exchange of the debt securities;
|
| • |
the denominations in which the offered debt securities will be issued (if other than $1,000 and any integral multiple thereof);
|
| • |
the provision for any sinking fund;
|
| • |
any restrictive covenants;
|
| • |
any Events of Default;
|
| • |
whether the series of debt securities is issuable in certificated form;
|
| • |
any provisions for defeasance or covenant defeasance;
|
| • |
any special U.S. federal income tax implications, including, if applicable, U.S. federal income tax considerations relating to original issue discount;
|
| • |
whether and under what circumstances we will pay additional amounts in respect of any tax, assessment or governmental charge and, if so, whether we will have the option to redeem the debt securities rather than pay the additional
amounts (and the terms of this option);
|
| • |
any provisions for convertibility or exchangeability of the debt securities into or for any other securities;
|
| • |
whether the debt securities are subject to subordination and the terms of such subordination;
|
| • |
whether the debt securities are secured and the terms of any security interest;
|
| • |
the listing, if any, on a securities exchange; and
|
| • |
any other terms.
|
| • |
how it handles securities payments and notices,
|
| • |
whether it imposes fees or charges,
|
| • |
how it would handle a request for the holders’ consent, if ever required,
|
| • |
whether and how you can instruct it to send you debt securities registered in your own name so you can be a holder, if that is permitted in the future for a particular series of debt securities,
|
| • |
how it would exercise rights under the debt securities if there were a default or other event triggering the need for holders to act to protect their interests, and
|
| • |
if the debt securities are in book-entry form, how the depositary’s rules and procedures will affect these matters.
|
| • |
An investor cannot cause the debt securities to be registered in his or her name, and cannot obtain certificates for his or her interest in the debt securities, except in the special situations we describe below.
|
| • |
An investor will be an indirect holder and must look to his or her own bank or broker for payments on the debt securities and protection of his or her legal rights relating to the debt securities, as we describe under “Issuance of
Securities in Registered Form” above.
|
| • |
An investor may not be able to sell interests in the debt securities to some insurance companies and other institutions that are required by law to own their securities in non-book-entry form.
|
| • |
An investor may not be able to pledge his or her interest in a global security in circumstances where certificates representing the debt securities must be delivered to the lender or other beneficiary of the pledge in order for the
pledge to be effective.
|
| • |
The depositary’s policies, which may change from time to time, will govern payments, transfers, exchanges and other matters relating to an investor’s interest in a global security. We and the trustee have no responsibility for any
aspect of the depositary’s actions or for its records of ownership interests in a global security. We and the trustee also do not supervise the depositary in any way.
|
| • |
If we redeem less than all the debt securities of a particular series being redeemed, DTC’s practice is to determine by lot the amount to be redeemed from each of its participants holding that series.
|
| • |
An investor is required to give notice of exercise of any option to elect repayment of its debt securities, through its participant, to the applicable trustee and to deliver the related debt securities by causing its participant to
transfer its interest in those debt securities, on DTC’s records, to the applicable trustee.
|
| • |
DTC requires that those who purchase and sell interests in a global security deposited in its book-entry system use immediately available funds. Your broker or bank may also require you to use immediately available funds when
purchasing or selling interests in a global security.
|
| • |
Financial institutions that participate in the depositary’s book-entry system, and through which an investor holds its interest in a global security, may also have their own policies affecting payments, notices and other matters
relating to the debt securities. There may be more than one financial intermediary in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries.
|
| • |
You must give your trustee written notice that an Event of Default with respect to the relevant series of debt securities has occurred and remains uncured.
|
| • |
The holders of at least 25% in principal amount of all outstanding debt securities of the relevant series must make a written request that the trustee take action because of the default and must offer to the trustee security or
indemnity satisfactory to it against the cost, expenses, and other liabilities of taking that action.
|
| • |
The trustee must not have taken action for 60 days after receipt of the above notice and offer of security or indemnity.
|
| • |
The holders of a majority in principal amount of the debt securities of that series must not have given the trustee a direction inconsistent with the above notice during that 60-day period.
|
| • |
in the payment of principal, any premium, or interest or
|
| • |
in respect of a covenant that cannot be modified or amended without the consent of each holder.
|
| • |
we are the surviving person (the “Surviving Person”) or the Surviving Person (if other than us) formed by such merger or consolidation or to which such sale, transfer, lease, conveyance or disposition is made shall be a corporation or
limited liability company organized and existing under the laws of the United States of America or any state or territory thereof;
|
| • |
the Surviving Person (if other than us) expressly assumes, by supplemental indenture in form reasonably satisfactory to the trustee, executed and delivered to the trustee by such Surviving Person, the due and punctual payment of the
principal of, and premium, if any, and interest on, all the Notes outstanding, and the due and punctual performance and observance of all the covenants and conditions of the indenture to be performed by us;
|
| • |
immediately before and immediately after giving effect to such transaction or series of related transactions, no default or Event of Default shall have occurred and be continuing; and
|
| • |
we shall deliver, or cause to be delivered, to the trustee, an officers’ certificate and an opinion of counsel, each stating that such transaction and the supplemental indenture, if any, in respect thereto, comply with this covenant,
that all conditions precedent in the indenture relating to such transaction have been complied with.
|
| • |
change the stated maturity of the principal of or interest on the debt securities;
|
| • |
reduce any amounts due on the debt securities;
|
| • |
reduce the amount of principal payable upon acceleration of the maturity of a security following a default;
|
| • |
adversely affect any right of repayment at the holder’s option;
|
| • |
change the place (except as otherwise described in the prospectus or prospectus supplement) or currency of payment on a debt security;
|
| • |
impair your right to sue for payment;
|
| • |
adversely affect any right to convert or exchange a debt security in accordance with its terms;
|
| • |
modify the subordination provisions in the indenture in a manner that is adverse to outstanding holders of the debt securities;
|
| • |
reduce the percentage of holders of debt securities whose consent is needed to modify or amend the indenture;
|
| • |
reduce the percentage of holders of debt securities whose consent is needed to waive compliance with certain provisions of the indenture or to waive certain defaults;
|
| • |
modify certain of the provisions of the indenture dealing with supplemental indentures, modification and waiver of past defaults, changes to the quorum or voting requirements or the waiver of certain covenants; and
|
| • |
change any obligation we have to pay additional amounts.
|
| • |
If the change affects only one series of debt securities, it must be approved by the holders of a majority in principal amount of that series.
|
| • |
If the change affects more than one series of debt securities issued under the same indenture, it must be approved by the holders of a majority in principal amount of all of the series affected by the change, with all affected series
voting together as one class for this purpose.
|
| • |
For original issue discount securities, we will use the principal amount that would be due and payable on the voting date if the maturity of these debt securities were accelerated to that date because of a default.
|
| • |
For debt securities whose principal amount is not known (for example, because it is based on an index), we will use a special rule for that debt security described in the prospectus supplement.
|
| • |
For debt securities denominated in one or more foreign currencies, we will use the U.S. dollar equivalent.
|
| • |
Debt securities will not be considered outstanding, and therefore not eligible to vote, if we have deposited or set aside in trust money for their payment or redemption. Debt securities will also not be eligible to vote if they have
been fully defeased as described later under “- Defeasance - Full Defeasance.”
|
| • |
If the debt securities of a particular series are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the debt securities of a particular series a combination of money and United States government or
United States government agency notes or bonds that will generate enough cash, in the opinion of a nationally recognized investment bank, appraisal firm or firm of independent public accountants, to make interest, principal and any other
payments on the debt securities of the particular series on their various due dates.
|
| • |
We must deliver to the trustee a legal opinion of our counsel confirming that, under current U.S. federal income tax law, we may make the above deposit without causing you to recognize income, gain or loss for U.S. federal income tax
purposes as a result of such covenant defeasance or to be taxed on the debt securities any differently than if we did not make the deposit and repaid the debt securities at maturity.
|
| • |
We must deliver to the trustee a legal opinion and officers’ certificate stating that all conditions precedent to covenant defeasance have been complied with.
|
| • |
Covenant defeasance must not result in a breach or violation of, or result in a default under, the indenture or any of our other material agreements or instruments.
|
| • |
No default or Event of Default with respect to such debt securities and any coupons appertaining thereto shall have occurred and be continuing and no defaults or events of default related to bankruptcy, insolvency or reorganization
shall occur during the next 90 days.
|
| • |
Satisfy the conditions for covenant defeasance contained in any supplemental indentures.
|
| • |
If the debt securities of a particular series are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the debt securities of a particular series a combination of money and United States government or
United States government agency notes or bonds that will generate enough cash, in the opinion of a nationally recognized investment bank, appraisal firm or firm of independent public accountants, to make interest, principal and any other
payments on the debt securities of the particular series on their various due dates.
|
| • |
We must deliver to the trustee a legal opinion confirming that there has been a change in current U.S. federal tax law or an IRS ruling that allows us to make the above deposit without causing you to recognize income, gain, or loss for
U.S. federal income tax purposes as a result of such defeasance or to be taxed on the debt securities any differently than if we did not make the deposit and repaid the debt securities at maturity. Under current U.S. federal tax law, the
deposit and our legal release from the debt securities would be treated as though we paid you your share of the cash and notes or bonds at the time the cash and notes or bonds were deposited in trust in exchange for your debt securities
and you would recognize gain or loss on the debt securities at the time of the deposit.
|
| • |
We must deliver to the trustee a legal opinion and officers’ certificate stating that all conditions precedent to defeasance have been complied with.
|
| • |
Defeasance must not result in a breach or violation of, or result in a default under, the indenture or any of our other material agreements or instruments.
|
| • |
No default or Event of Default with respect to such debt securities and any coupons appertaining thereto shall have occurred and be continuing and no defaults or events of default related to bankruptcy, insolvency or reorganization
shall occur during the next 90 days.
|
| • |
Satisfy the conditions for covenant defeasance contained in any supplemental indentures.
|
| • |
only in fully registered certificated form,
|
| • |
without interest coupons, and
|
| • |
unless we indicate otherwise in the prospectus supplement, in denominations of $1,000 and amounts that are multiples of $1,000.
|
| • |
our indebtedness (including indebtedness of others guaranteed by us), whenever created, incurred, assumed or guaranteed, for money borrowed (other than indenture securities issued under the indenture and denominated as subordinated
debt securities), unless in the instrument creating or evidencing the same or under which the same is outstanding it is provided that this indebtedness is not senior or prior in right of payment to the subordinated debt securities, and
|
| • |
renewals, extensions, modifications and refinancings of any of this indebtedness.
|
| • |
a limited purpose trust company organized under the laws of the State of New York;
|
| • |
a “banking organization” within the meaning of the New York State Banking Law;
|
| • |
a member of the Federal Reserve System;
|
| • |
a “clearing corporation” within the meaning of the Uniform Commercial Code; and
|
| • |
a “clearing agency” registered under Section 17A of the Exchange Act.
|
| • |
the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances the securities comprising the units may be held or transferred separately;
|
| • |
a description of the terms of any unit agreement governing the units;
|
| • |
a description of the provisions for the payment, settlement, transfer or exchange of the units; and
|
| • |
whether the units will be issued in fully registered or global form.
|
| • |
our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on March 19, 2026;
|
| • |
our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 30, 2026;
|
| • |
the description of our common stock referenced in our Registration Statement on Form 8-A (No. 001-40564), as filed with the SEC on June 29, 2021, including any amendment or report filed for the purpose of updating such description prior to the termination of the
offering of the common stock registered hereby.
|
| Item 25. |
Financial Statements and Exhibits
|
| (1) |
Financial Statements
|
|
(2)
|
Exhibits
|
| a.1. |
| a.2. |
| b. |
| c. |
Not Applicable
|
| d.1. |
Form of Indenture**
|
| d.2. |
Statement of Eligibility of Trustee on Form T-1**
|
| e. |
Not Applicable
|
| f. |
Not Applicable
|
| g. |
| h.1. |
Form of Underwriting Agreement for Equity Securities**
|
| h.2. |
Form of Underwriting Agreement for Debt Securities**
|
| i. |
Not Applicable
|
| j.1. |
| j.2. |
| k.1. |
| k.2. |
| k.3. |
| k.4. |
| l. |
Opinion and Consent of Baker, Donelson, Bearman, Caldwell & Berkowitz, PC**
|
| m. |
Not Applicable
|
| n.1. |
| n.2. |
| o. |
Not Applicable
|
| p. |
Not Applicable
|
| q. |
Not Applicable
|
| r.1. |
| r.2. |
| s. |
| * |
Filed herewith.
|
| ** |
To be filed either by amendment or as an exhibit to a report filed under the Securities Exchange Act of 1934 and incorporated herein by reference.
|
|
Item 26.
|
Marketing Arrangements
|
|
Item 27.
|
Other Expenses of Issuance and Distribution
|
|
U.S. Securities and Exchange Commission registration fee
|
$ |
69,050
|
||
|
FINRA filing fee(1)
|
$
|
—
|
||
|
NASDAQ listing fee(1)
|
$
|
—
|
||
|
Printing expenses(1)
|
$
|
—
|
||
|
Legal fees and expenses(1)
|
$
|
—
|
||
|
Accounting fees and expenses(1)
|
$
|
—
|
||
|
Miscellaneous fees and expenses(1)
|
$
|
—
|
||
|
Total
|
$
|
—
|
| (1) |
These fees will be calculated based on the securities offered and the number of issuances and accordingly, cannot be estimated at this time. These fees, if any, will be reflected in the applicable prospectus supplement.
|
| Item 28. |
Persons Controlled by or Under Common Control
|
| Item 29. |
Number of Holders of Securities
|
|
Title of Class
|
Number of
Record Holders
|
|||
|
Common Stock
|
114
|
|
||
| Item 30. |
Indemnification
|
| Item 31. |
Business and Other Connections of Investment Adviser
|
| Item 32. |
Location of Accounts and Records
|
| Item 33. |
Management Services
|
| Item 34. |
Undertakings
|
|
(1)
|
Not Applicable
|
|
(2)
|
Not Applicable
|
|
(3)
|
Registrant undertakes:
|
| (a) |
to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
|
(1)
|
to include any prospectus required by Section 10(a)(3) of the Securities Act;
|
| (2) |
to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental
change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” in the effective registration statement; and
|
| (3) |
to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.
|
| (b) |
that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of those
securities at that time shall be deemed to be the initial bona fide offering thereof;
|
| (c) |
to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering;
|
|
(d)
|
that, for the purpose of determining liability under the Securities Act to any purchaser:
|
|
(1)
|
if the Registrant is relying on Rule 430B:
|
| (A) |
Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
|
| (B) |
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (x), or (xi) for the purpose of
providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or
the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed
to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed
incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement
that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or
|
|
(2)
|
if the Registrant is subject to Rule 430C: each prospectus filed pursuant to Rule 424(b) under the Securities Act as part of a registration statement relating to an offering, other than registration
statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the
registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.
|
| (e) |
that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of securities:
|
|
(1)
|
any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424 under the Securities Act;
|
|
(2)
|
free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant;
|
| (3) |
the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities Act relating to the offering containing material information about the undersigned Registrant or its securities provided by or
on behalf of the undersigned Registrant; and
|
|
(4)
|
any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.
|
|
(4)
|
Not Applicable
|
| (5) |
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is
incorporated by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.
|
| (6) |
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant, the Registrant has been advised that in the opinion of the SEC such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
|
| (7) |
Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt of a written or oral request, any prospectus.
|
|
CHICAGO ATLANTIC BDC, INC.
|
|||
|
By:
|
/s/ Peter Sack
|
||
|
Name:
|
Peter Sack
|
||
|
Title:
|
Chief Executive Officer
|
||
|
Name
|
Title
|
|
|
/s/ Scott Gordon
|
Director, Executive Chairman of the
|
|
|
Scott Gordon
|
Board of Directors, and Co-Chief Investment Officer
|
|
|
/s/ Michael W. Chorske *
|
Director
|
|
|
Michael W. Chorske
|
||
|
/s/ Americo Da Corte *
|
||
|
Americo Da Corte
|
Director
|
|
|
/s/ Supurna VedBrat*
|
||
|
Supurna VedBrat
|
Director
|
|
|
/s/ Tracey Brophy Warson *
|
||
|
Tracey Brophy Warson
|
Director
|
|
|
/s/ Peter Sack
|
Chief Executive Officer
|
|
|
Peter Sack
|
(Principal Executive Officer)
|
|
|
/s/ Thomas Geoffroy
|
Interim Chief Financial Officer
|
|
|
Thomas Geoffroy
|
(Principal Financial Officer)
|
|
*By:
|
/s/ Peter Sack
|
|
|
Peter Sack
|
||
|
**Attorney-in-Fact
|
| ** |
Signed by Peter Sack pursuant to a power of attorney signed by each individual and filed herewith.
|